Molecular mechanisms of dystonia and spastic paraplegia associated with mutations in ATP5G3
与 ATP5G3 突变相关的肌张力障碍和痉挛性截瘫的分子机制
基本信息
- 批准号:10799993
- 负责人:
- 金额:$ 40.66万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-04-01 至 2025-03-31
- 项目状态:未结题
- 来源:
- 关键词:AllelesAmino Acid SubstitutionAnimal ModelBehavioralBehavioral AssayBiochemicalBiologicalBiological ModelsCell Culture TechniquesCellsCharacteristicsClinical TreatmentClustered Regularly Interspaced Short Palindromic RepeatsCodeComplexCorpus striatum structureCorticospinal TractsDNADefectDiseaseDominant Genetic ConditionsDominant-Negative MutationDrosophila genusDystoniaElectrophysiology (science)EquilibriumEscherichia coliFamilyFibroblastsFocal DystoniasFunctional disorderGait abnormalityGenesGeneticGenetic DiseasesHeterozygoteHumanInheritedInsectaInvestigationInvoluntary MovementsKnock-outKnockout MiceLegLimb structureLinkLower ExtremityMammalsMissense MutationMitochondriaModelingMolecularMolecular AnalysisMovementMusMuscleMuscle ContractionMutant Strains MiceMutationNatureNeurologicNeurologic DysfunctionsNeuronal PlasticityOrthologous GeneOsteogenesis ImperfectaPathogenicityPathologicPathologyPathway interactionsPatientsPatternPenetrancePhenotypeProbabilityProductionProteinsProtonsPublishingReportingRoleSmooth MuscleSpastic ParaplegiaSynaptic TransmissionSystemTestingThalamic structureVariantage relatedautosomal dominant mutationautosomebase editingcitrate carrierde novo mutationeffective therapyexperimental studyflygenetic analysisin vitro Modelin vivoinsightlimb movementmouse modelmutantnervous system disorderneuromuscularnoveloligomycin sensitivity-conferring proteinoverexpressionspasticity
项目摘要
Dystonia and spastic paraplegia are debilitating neurological conditions with distinct signs and underlying
pathophysiology. Dystonia describes a range of conditions characterized by involuntary muscle contraction,
while spastic paraplegias are characterized by progressive weakness and stiffness of the leg muscles.
Previously, a large family was published displaying an autosomal dominant pattern of progressive, age-
dependent spastic paraplegia and incomplete penetrance for generalized and focal dystonia. Genetic analysis
showed that both phenotypes were connected to a single novel missense mutation in the gene ATP5G3
(c.318C>G, p.N106K), which encodes subunit c of ATP synthase. Recently, the pathology of this variant was
confirmed by the identification of a dystonia patient from a second family who was found to be carrying the same
mutation as a de novo mutation. Further experiments demonstrated that ATP production and complex V activity
were significantly reduced in patient fibroblasts, consistent with the predicted role of ATP5G3. As additional
confirmation, experiments were also performed in Drosophila utilizing overexpression of the equivalent missense
mutation, which resulted in a significant disruption in the flies’ locomotor ability and complex V activity. Based on
these preliminary results, the central hypothesis of this proposal is that the p.N106K mutation acts in a dominant
negative manner to disrupt complex V function, leading to the dystonia and spastic paraplegia phenotype. This
hypothesis will be tested using three complementary approaches. First, experiments will be performed to
characterize a newly generated mouse model carrying a missense mutation equivalent to the pathogenic human
mutation (p.N105K) using behavioral, molecular, and electrophysiological approaches. Second, the biochemical
mechanisms of the p.N106K mutation will be elucidated using the E. coli ATP synthase system. Specifically,
mutations will generated with the equivalent “humanized” substitutions for suspected autosomal dominant
ATP5G3 mutations in the bacterial subunit c protein. The biochemical effects of each of these substitutions will
then be explored in the bacterial ATP Synthase, particularly as it relates to assembly of the c-ring, the physical
interaction of the F1 the Fo complexes, and/or proton translocation. Finally, effective therapies will be developed
for the ATP5G3N106K mutation by using CRISPR-based gene editing to inactivate the dominant p.N106K allele in
patient fibroblasts. After optimizing the editing efficiency in cell culture, the feasibility of using CRISPR-based
inactivation as an in vivo treatment approach will be evaluated using Atp5g3N105K mutant mice. The results of this
experiment will help lay the groundwork for developing CRISPR-based editing as a possible treatment for genetic
diseases caused by dominant negative mutation such as osteogenesis imperfecta, which is probably the only
option for treatment. This comprehensive characterization of these ATP5G3 mutations will yield valuable insights
into dystonia and spastic paraplegia, complex V functionality, and the pathology and treatment of autosomal
dominant genetic diseases, particularly those caused by dominant negative mutations.
肌张力障碍和痉挛性截瘫是使人衰弱的神经系统疾病,具有明显的体征和潜在的症状
病理生理学。肌张力障碍描述了一系列以肌肉不自主收缩为特征的病症,
而痉挛性截瘫的特点是腿部肌肉进行性无力和僵硬。
此前,发表的一个大家族显示出渐进的、年龄相关的常染色体显性模式。
依赖性痉挛性截瘫和全身性和局灶性肌张力障碍的不完全外显率。遗传分析
显示这两种表型都与 ATP5G3 基因中的一个新错义突变有关
(c.318C>G, p.N106K),编码 ATP 合酶的 c 亚基。最近,该变异的病理学是
经第二个家庭的一名肌张力障碍患者的鉴定证实,该患者被发现携带同样的肌张力障碍
突变为从头突变。进一步的实验表明 ATP 产生和复合 V 活性
患者成纤维细胞中的 ATP5G3 显着减少,与 ATP5G3 的预测作用一致。作为附加
确认后,还在果蝇中进行了利用等效错义过表达的实验
突变,导致果蝇的运动能力和复合 V 活性显着破坏。基于
根据这些初步结果,该提案的中心假设是 p.N106K 突变以显性作用
负面方式破坏复合体 V 功能,导致肌张力障碍和痉挛性截瘫表型。这
将使用三种互补的方法来检验假设。首先,将进行实验
描述了新生成的小鼠模型,其携带与致病性人类相当的错义突变
使用行为、分子和电生理学方法进行突变(p.N105K)。二、生化
p.N106K 突变的机制将使用大肠杆菌 ATP 合酶系统来阐明。具体来说,
突变将通过对疑似常染色体显性遗传的等效“人源化”替换而产生
细菌 c 亚基蛋白中的 ATP5G3 突变。这些替代的生化效应将
然后在细菌 ATP 合酶中进行探索,特别是因为它与 C 环的组装有关,即物理
F1 与 Fo 复合物的相互作用,和/或质子易位。最终,将开发出有效的治疗方法
通过使用基于 CRISPR 的基因编辑来灭活 ATP5G3N106K 突变中的显性 p.N106K 等位基因
患者的成纤维细胞。优化细胞培养中的编辑效率后,使用基于 CRISPR 的可行性
将使用 Atp5g3N105K 突变小鼠评估失活作为体内治疗方法。这样做的结果
实验将有助于为开发基于 CRISPR 的编辑作为遗传性疾病的可能治疗方法奠定基础
由显性失活突变引起的疾病,例如成骨不全症,这可能是唯一的
治疗的选择。这些 ATP5G3 突变的全面表征将产生有价值的见解
肌张力障碍和痉挛性截瘫、复杂 V 功能以及常染色体病理学和治疗
显性遗传疾病,特别是由显性失活突变引起的疾病。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jesse David Slone其他文献
Jesse David Slone的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似海外基金
Phenotypic consequences of a modern human-specific amino acid substitution in ADSL
ADSL 中现代人类特异性氨基酸取代的表型后果
- 批准号:
24K18167 - 财政年份:2024
- 资助金额:
$ 40.66万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Estimation of stability and functional changes due to amino acid substitution using molecular simulations
使用分子模拟估计氨基酸取代引起的稳定性和功能变化
- 批准号:
20H03230 - 财政年份:2020
- 资助金额:
$ 40.66万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Elucidation of the mechanisms of prion protein conversion caused by an amino acid substitution in glycosylphosphatidylinositol anchoring signal peptide
阐明糖基磷脂酰肌醇锚定信号肽中氨基酸取代引起的朊病毒蛋白转化机制
- 批准号:
16K18790 - 财政年份:2016
- 资助金额:
$ 40.66万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Amino acid substitution without genetic modification
无需基因改造的氨基酸替代
- 批准号:
15H05491 - 财政年份:2015
- 资助金额:
$ 40.66万 - 项目类别:
Grant-in-Aid for Young Scientists (A)
Study on PSII hydrogen bond networks by exhaustive amino acid substitution
穷举氨基酸取代研究PSII氢键网络
- 批准号:
15K07110 - 财政年份:2015
- 资助金额:
$ 40.66万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Elucidation of the effect of HCV propagationa and IFN sensitivity by amino acid substitution in interferon sensitivity-determining region.
阐明干扰素敏感性决定区氨基酸取代对 HCV 传播和干扰素敏感性的影响。
- 批准号:
26860309 - 财政年份:2014
- 资助金额:
$ 40.66万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
The analysis of the restriction of amino acid substitution on the hemagglutinin molecule of influenza A virus
甲型流感病毒血凝素分子氨基酸取代限制性分析
- 批准号:
14370104 - 财政年份:2002
- 资助金额:
$ 40.66万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Changes in the Substrate Specificities of Farnesyl Diphosphate Synthase by a Single Amino Acid Substitution
单一氨基酸取代对法尼基二磷酸合酶底物特异性的变化
- 批准号:
12680587 - 财政年份:2000
- 资助金额:
$ 40.66万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Analyses of the Relationship between Amino Acid Substitution and Phenotype of the Tail Sheath Protein of Bacteriophage T4
噬菌体T4尾鞘蛋白氨基酸取代与表型关系分析
- 批准号:
02680125 - 财政年份:1990
- 资助金额:
$ 40.66万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
Hypothesis: Both appearance and disappearance of viruses are controlled by the accumulation of amino acid substitution in receptor binding domain
假设:病毒的出现和消失都是由受体结合域氨基酸取代的积累控制的
- 批准号:
02454184 - 财政年份:1990
- 资助金额:
$ 40.66万 - 项目类别:
Grant-in-Aid for General Scientific Research (B)














{{item.name}}会员




